Last updated: 2026-09-17
Steadier control for colon checks — Tutorial
Colon checks can miss spots when the long flexible scope won’t stay steady — steadier control aims for a thorough look and treatment in the same visit. A colonoscope is powerful because it bends — and that bendiness is why thoroughness is hard. Steadier control aims to finish looking and treating in one visit. Clearance news is not every clinic tomorrow.
| Page | Title | Concept (one line) | When the tutor offers it | Illustration |
|---|---|---|---|---|
| 01 | A shaky scope can miss spots | Looping and tip drift hide spots behind folds. | First beat, before same-visit job. | 01 |
| 02 | Look, find, and treat in the same visit | Find and remove early growths in one sitting. | After shaky mechanism; before regulatory news. | 02 |
| 03 | Robotic help cleared a regulatory gate | Sep 2026 clearance news — capability class, not a brand answer. | After same-visit job; before the one idea. | 03 |
| 04 | Steadier control aims for a thorough look and treat | Colon checks can miss spots when the long flexible scope won’t stay steady — steadier control aims for a thorough look and treatment in the same visit. | Core one idea after the job and the news. | 04 |
| 05 | Less fight for the doctor’s hands | Lower physical strain; keep the trained human. | After the one idea; before honest limits. | 05 |
| 06 | Cleared is not everywhere yet | Clearance ≠ every clinic floor tomorrow. | After ergonomics; before invent. | 06 |
| 07 | Invent a thorough look without the shaky fight | Open invent for Steadybend — no prescribed brand. | Last page / invent gate. | — |
Sources
- FDA Accessdata / Innolitics — K260503 Triton 1 System (decision 3 Sep 2026; Class II; SESE)
- Neptune Medical via BioSpace / Business Wire — FDA clearance announcement (16 Sep 2026; org self-report)
- MassDevice / MedTech Dive / Robotics Business News — CARE 1 first-in-human coverage (May 2026; company-reported numbers)
- ACG/ASGE 2024 quality indicators — priority ADR > 35% (Rex et al. / Schoenfeld EBGI summary)
- FDA Premarket Notification 510(k) overview — substantial equivalence definition
- American Cancer Society — colorectal cancer key statistics / 2026 materials (independent epidemiology)